BioSpace News Archive

Phio Pharmaceuticals Corp. reported its financial results for the first quarter ended March 31, 2019 and provided a business update.

Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation and certain of its officers.

Two Competitions Give Entrepreneurs Access to Feedback and Capital

Medvantx, Inc., the leading provider of ecommerce enabled pharmacy solutions, is pleased to announce the addition of Slater Nash, as Chief Pharmacy Officer.

Titan Medical Inc. announces financial results for the three months ended March 31, 2019.

Aurora Cannabis Inc. announced its financial and operational results for the third quarter ended March 31st, 2019.

Pneuma Respiratory, Inc., developer of a proprietary breath-activated digital inhaler (BDI), and Leads Biolabs Inc. announce an agreement granting Pneuma an exclusive license to develop Leads Biolabs’ panel of immuno-oncology monoclonal antibodies and fusion protein molecules for the pulmonary delivery of Leads’ antibodies and molecules.

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) announced that the US Food and Drug Administration (FDA) has approved BAVENCIO® (avelumab) in combination with INLYTA® (axitinib) for the first-line treatment of patients with advanced renal cell carcinoma (RCC).

Veeva Systems (NYSE:VEEV) today announced two new innovations in Veeva CRM that continue to advance compliance and digital engagement in the life sciences industry.

Thermo Fisher Scientific has developed a new Total Residual Oxidant (TRO) analyzer to address the needs of the wastewater industry, which calls for a robust, dependable instrument capable of reliably measuring low ppb chlorine concentrations in effluent and treated wastewater in line with stringent regulatory requirements.